Quest Diagnostics

Quest Diagnostics EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Diagnostics (DGX) as of Nov 20, 2026 is 15.65. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 22.15 — a change of -29.36% (lower).

EV/OCF

15.65

YoY

-29.36%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Diagnostics is 2025 15.65 . EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Diagnostics was 2024 22.15 . It decreases by -29.36% lower compared to the previous year.

The Quest Diagnostics EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
22.39 USD
Jan 1, 2019
21.91 USD
Jan 1, 2020
13.30 USD
Jan 1, 2021
12.05 USD
Jan 1, 2022
15.96 USD
Jan 1, 2023
21.87 USD
Jan 1, 2024
22.15 USD
Jan 1, 2025
15.65 USD
The Quest Diagnostics EV/OCF history
YEAREV/OCFYoY
15.65-29.36%
22.15+1.27%
21.87+37.10%
15.96+32.38%
12.05-9.37%
13.30-39.31%
21.91-2.14%
22.39-1.58%
22.75-7.84%
24.68-24.64%
32.75+15.57%
28.34—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Diagnostics Stock analysis

What does Quest Diagnostics do? Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quest Diagnostics stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Diagnostics is 15.65 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Diagnostics changed from 22.15 to 15.65, representing a -29.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Quest Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Quest Diagnostics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Quest Diagnostics

All Key Metrics — Quest Diagnostics